Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-04-04 19:03 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$38,846
+6,296 vol $6.17 each |
6,296 | |
Filed 2025-04-04 19:02 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2025-04-04 18:58 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-40,382.71
-7,751 vol $5.21 each |
33,270 | |
Filed 2025-04-04 18:56 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-20,188.75
-3,875 vol $5.21 each |
16,635 | |
Filed 2025-03-29 16:29 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$36,440
+5,868 vol $6.21 each |
20,510 | |
Filed 2025-03-29 16:28 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$72,874
+11,735 vol $6.21 each |
41,021 | |
Filed 2025-03-29 16:27 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$111,742
+17,994 vol $6.21 each |
64,141 | |
Filed 2024-08-26 14:17 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,457
+5,058 vol $4.44 each |
8,933 | |
Filed 2024-08-26 14:17 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
50 - Grant of options
|
$44,923
+10,118 vol $4.44 each |
17,869 | |
Filed 2024-08-26 14:16 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72,358
+16,297 vol $4.44 each |
29,525 | |
Filed 2023-04-03 21:55 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,128
+4,984 vol $4.44 each |
||
Filed 2023-04-03 21:54 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
50 - Grant of options
|
$44,253
+9,967 vol $4.44 each |
||
Filed 2023-04-03 21:49 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,284
+16,055 vol $4.44 each |
||
Filed 2024-04-25 14:11 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$95,077
+16,622 vol $5.72 each |
45,905 | |
Filed 2024-04-16 18:39 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,346
+16,552 vol $5.70 each |
||
Filed 2024-04-16 18:42 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$32,541
+5,709 vol $5.70 each |
14,568 | |
Filed 2024-04-16 18:40 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$65,076
+11,417 vol $5.70 each |
29,135 | |
Filed 2024-04-16 18:39 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,346
+16,552 vol $5.70 each |
45,835 | |
Filed 2023-04-03 21:55 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,128
+4,984 vol $4.44 each |
8,859 | |
Filed 2023-04-03 21:54 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
50 - Grant of options
|
$44,253
+9,967 vol $4.44 each |
17,718 | |
Filed 2023-04-03 21:49 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,284
+16,055 vol $4.44 each |
29,283 | |
Filed 2022-09-15 10:54 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,188
+3,875 vol $5.21 each |
3,875 | |
Filed 2022-09-15 10:49 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,188
+3,875 vol $5.21 each |
||
Filed 2022-09-15 10:48 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$40,382
+7,751 vol $5.21 each |
7,751 | |
Filed 2022-09-15 10:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,917
+13,228 vol $5.21 each |
13,228 | |
Filed 2022-03-29 11:41 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$21,876
+4,199 vol $5.21 each |
||
Filed 2022-03-29 11:40 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$43,748
+8,397 vol $5.21 each |
||
Filed 2022-03-29 11:39 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,659
+14,330 vol $5.21 each |
||
Filed 2022-03-29 11:41 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
Filed 2022-03-29 11:40 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:40 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
Filed 2022-03-29 11:39 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:39 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,659
+14,330 vol $5.21 each |
14,330 | |
Filed 2022-03-29 11:38 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|